Skip to main content
. 2022 Nov 17;17(11):e0277200. doi: 10.1371/journal.pone.0277200

Table 3. Histological analysis of the lesions.

n Percentage
Thymoma 14 29,2%
Lymphoma 7 14,6%
Carcinoma (primary or metastasis) 11 22,9%
Other malignancies 3 6,3%
Benign 11 22,9%
Inconclusive 2 4,2%
Total 48 100%